ArticleMedical oncology (Northwood, London, England)2014

Evaluation of soluble CD44 protein marker to distinguish the premalignant and malignant carcinoma cases in cervical cancer patients.

Subramanyam Dasari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.